Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

  1. Rodriguez-Vida, A.
  2. Valderrama, B.P.
  3. Castellano, D.
  4. Pinto, A.
  5. Mellado, B.
  6. Puente, J.
  7. Climent, M.A.
  8. Domenech, M.
  9. Vazquez, F.
  10. Perez-Gracia, J.L.
  11. Bonfill, T.
  12. Morales-Barrera, R.
  13. Gonzalez-Billalabeitia, E.
  14. Garcia-del-Muro, X.
  15. Maroto, P.
  16. Navarro-Gorro, N.
  17. Juanpere, N.
  18. Juan, O.
  19. Bellmunt, J.
Revista:
ESMO Open

ISSN: 2059-7029

Any de publicació: 2024

Volum: 9

Número: 9

Tipus: Article

DOI: 10.1016/J.ESMOOP.2024.103690 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus